The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.

Dev S. Ancient-modern concordance in Ayurvedic plants: some examples. Environ Health Perspect 1999;107:783-9. View abstract.

GRIN Taxonomy. Available at: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl? (Accessed 27 February 2000).

Jacob A, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr 1988;42:939-44. View abstract.

Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol 1993;45:581-4. View abstract.

Ihantola-Vormisto A, Summanen J, Kankaanranta H, et al. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 1997;63:518-24. View abstract.

Hu JF. [Inhibitory effects of Phyllanthus emblica juice on formation of N-nitrosomorpholine in vitro and N-nitrosoproline in rat and human]. Chung Hua Yu Fang I Hsueh Tsa Chih 1990;24:132-5. View abstract.

Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999;37:676-80. View abstract.

Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing 1996;202.

Anila L, Vijayalakshmi NR. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 2000;14:592-5. View abstract.

Chaudhuri, R. K. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol 2002;15(5):374-380. View abstract.

Scartezzini, P. and Speroni, E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000;71(1-2):23-43. View abstract.

Jose, J. K., Kuttan, G., and Kuttan, R. Antitumour activity of Emblica officinalis. J Ethnopharmacol. 2001;75(2-3):65-69. View abstract.

Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. View abstract.

Al Rehaily, A. J., Al Howiriny, T. A., Al Sohaibani, M. O., and Rafatullah, S. Gastroprotective effects of 'Amla' Emblica officinalis on in vivo test models in rats. Phytomedicine. 2002;9(6):515-522. View abstract.

Lambertini, E., Piva, R., Khan, M. T., Lampronti, I., Bianchi, N., Borgatti, M., and Gambari, R. Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Oncol. 2004;24(2):419-423. View abstract.

Bafna, P. A. and Balaraman, R. Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine. 2005;12(4):264-270. View abstract.

Lambertini, E., Lampronti, I., Penolazzi, L., Khan, M. T., Ather, A., Giorgi, G., Gambari, R., and Piva, R. Expression of estrogen receptor alpha gene in breast cancer cells treated with transcription factor decoy is modulated by Bangladeshi natural plant extracts. Oncol.Res. 2005;15(2):69-79. View abstract.

Yokozawa, T., Kim, H. Y., Kim, H. J., Okubo, T., Chu, D. C., and Juneja, L. R. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br.J Nutr. 2007;97(6):1187-1195. View abstract.

Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 2013;52(8):1408-17. View abstract.

Colucci R, Dragoni F, Conti R, Pisaneschi L, Lazzeri L, Moretti S. Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Dermatol Ther. 2015;28(1):17-21. View abstract.

Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579-85. View abstract.

Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18(4):415-20. View abstract.

Upadya H, Prabhu S, Prasad A, Subramanian D, Gupta S, Goel A. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC Complement Altern Med. 2019;19(1):27. View abstract.

Gao Q, Li X, Huang H, Guan Y, Mi Q, Yao J. The efficacy of a chewing gum containing Phyllanthus emblica fruit extract in improving oral health. Curr Microbiol. 2018;75(5):604-610. View abstract.

Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial. J Integr Med. 2018;16(2):126-131. View abstract.

Antony B, Benny M, Kaimal TN. A pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax) on markers of systemic inflammation and dyslipidemia. Indian J Clin Biochem. 2008;23(4):378-81. View abstract.

Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012;44(2):238-42. View abstract.

Kapoor MP, Suzuki K, Derek T, Ozeki M, Okubo T. Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study. Contemp Clin Trials Commun 2019;17:100499. View abstract.

Uchiyama T, Tsunenaga M, Miyanaga M, Ueda O, Ogo M. Oral intake of lingonberry and amla fruit extract improves skin conditions in healthy female subjects: a randomized, double-blind, placebo-controlled clinical trial. Biotechnol Appl Biochem 2019;66(5):870-9. View abstract.

Usharani P, Merugu PL, Nutalapati C. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study. BMC Complement Altern Med 2019;19(1):97. View abstract.

Ghaffari S, Navabzadeh M, Ziaee M, Ghobadi A, Ghods R, Hashem-Dabaghian F. A randomized, triple-blind, placebo-controlled, add-on clinical trial to evaluate the efficacy of Emblica officinalis in uncontrolled hypertension. Evid Based Complement Alternat Med. 2020;2020:8592869. View abstract.

Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P, Shah K. Clinical study to evaluate the efficacy and safety of a hair serum product in healthy adult male and female volunteers with hair fall. Clin Cosmet Investig Dermatol. 2020;13:691-700. View abstract.

Shanmugarajan D, Girish C, Harivenkatesh N, Chanaveerappa B, Prasanna Lakshmi NC. Antihypertensive and pleiotropic effects of Phyllanthus emblica extract as an add-on therapy in patients with essential hypertension-A randomized double-blind placebo-controlled trial. Phytother Res. 2021;35(6):3275-3285. View abstract.

Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(6):609-16. View abstract.

Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013;6:275-84. View abstract.

Grover S, Tewari S, Sharma RK, Singh G, Yadav A, Naula SC. Effect of subgingivally delivered 10% Emblica officinalis gel as an adjunct to scaling and root planing in the treatment of chronic periodontitis - A randomized placebo-controlled clinical trial. Phytother Res. 2016;30(6):956-62. View abstract.

Varnasseri M, Siahpoosh A, Hoseinynejad K, et al. The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial. Complement Ther Med 2022;65:102808. View abstract.

Hegde SK, Rao S, Rao P, Raghu SV, Meera S, Baliga MS. Aqueous Extract of Emblica officinalis Linn (Indian gooseberry) in Combination with Iodine is More Efficacious than Iodine Alone in Mitigating Mucositis in Head and Neck Cancer Patients Undergoing Curative Radiotherapy: Retrospective Observations. Indian J Otolaryngol Head Neck Surg 2022;74(Suppl 3):6330-6338. View abstract.

Brown PDS, Ketter N, Vis-Dunbar M, Sakakibara BM. Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis. BMC Complement Med Ther 2023;23(1):190. View abstract.

Setayesh L, Haghighat N, Rasaei N, et al. The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2023;17(3):102729. View abstract.

Majeed M, Mundkur L, Paulose S, Nagabhushanam K. Novel Emblica officinalis extract containing ß-glucogallin vs. metformin: a randomized, open-label, comparative efficacy study in newly diagnosed type 2 diabetes mellitus patients with dyslipidemia. Food Funct 2022;13(18):9523-9531. View abstract.

Moazzam SW, Mobeen A, Siddiqui MA. Efficacy of Jawarish Shahi a herbal formulation in irritable bowel syndrome: An open-labeled single-arm clinical trial. J Tradit Complement Med 2022;12(6):529-535. View abstract.

Poomanee W, Yaowiwat N, Pattarachaidaecharuch T, Leelapornpisid P. Optimized multiherbal combination and in vivo anti-skin aging potential: a randomized double blind placebo controlled study. Sci Rep 2023;13(1):5633. View abstract.